03242017Headline:

New York, New York

HomeNew YorkNew York

Kendra Goldhirsch

Xarelto Manufacturers Eye New Patient Population as Lawsuits Continue

The anticoagulant drug Xarelto (rivaroxaban) is currently the subject of over 15,000 personal injury lawsuits pending in the Eastern District of Louisiana in a consolidated MDL litigation. Plaintiffs in these suits allege that after taking the drug, they suffered excessive […]

Roopal Luhana

FDA Drafts Guidelines on Off-Label Prescription Drug Marketing

Plaintiffs who file personal injury lawsuits against prescription drug manufacturers typically assert failure to warn claims, which provide that the drug makers failed to provide adequate warnings about the risks associated with their products. Instead, they argue that the manufacturers […]

Kendra Goldhirsch

JPML Consolidates Eliquis Litigation in New York

In October 2016, Eliquis manufacturers Bristol-Meyers Squibb and Pfizer Inc. submitted a petition to the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all Eliquis lawsuits into one court for pre-trial proceedings. They argued at the time that coordination […]

Roopal Luhana

Judge Fallon Sets New Dates for Xarelto Bellwether Trials

According to a recent Case Management Order entered in the Xarelto Multidistrict Litigation in federal court (Xarelto MDL), the first Xarelto bellwether trials have been delayed. The U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally filed Xarelto lawsuits […]

Dori Milner

Eliquis Lawsuits Increase in Number as Questions Surround Clinical Trial

Over the past several months, plaintiffs have been filing product liability lawsuits against Eliquis manufacturers Bristol-Myers Squibb and Pfizer, Inc. As of December 2016, there were about 34 Eliquis lawsuits pending in different courts around the country. In each, plaintiffs […]

Roopal Luhana

Widower Brings Claims Against Xarelto Manufacturers for Wife’s Death

A Louisiana man has filed a new Xarelto lawsuit on behalf of his spouse, who died after taking the blood-thinning drug. He filed his case in the U.S. District Court for the Eastern District of Louisiana, joining the current Xarelto […]

Roopal Luhana

Xarelto Manufacturers Doled Out Millions to Persuade Doctors to Prescribe

A new report by the independent, public-interest news organization ProPublica indicates that manufacturers spent more on physician payments for Xarelto than any other drug in 2015. Payments were for things such as promotional speaking, consulting, meals, travel, gifts and royalties, […]

Roopal Luhana

Number of Cases in Xarelto MDL Nears 14,000

It was over two years ago now that the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally filed Xarelto lawsuits into one court in the Eastern District of Louisiana. Now, there are over 13,000 cases pending in that […]

Dori Milner

Xarelto Mass Tort Adopts MDL Bellwether Selection Process

In January 2015, Philadelphia Court of Common Pleas Judge Kevin Dougherty created a mass tort docket for all state-filed Xarelto lawsuits. At that time, about 75 cases were centralized in the same court, with plaintiffs alleging excessive bleeding injuries after […]

Roopal Luhana

Number of PPI Lawsuits Increasing in Federal Courts

The number of lawsuits filed against the makers of heartburn drugs like Nexium and Prilosec continues to increase. These drugs belong to a class of medications called “proton pump inhibitors (PPIs)”. They reduce the production of stomach acid and are […]